Global Burn and Scald Medicine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Page: 176
Published Date: 28 Mar 2025
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Burn and Scald Medicine market size was valued at US$ 467 million in 2024 and is forecast to a readjusted size of USD 615 million by 2031 with a CAGR of 3.6% during review period.
Burns are a common traumatic disease caused by physical or chemical factors, such as heat, chemistry, electric current and radiation. Small-area burns only cause damage to the skin and (or) mucosal tissue or the corresponding deep tissue. However, larger-area burns can cause functional, metabolic and morphological changes in various systems of the body to varying degrees, causing severe systemic reactions and visceral damage in the injured, and complications such as shock, sepsis and multiple organ failure, with a high mortality rate. The healing and treatment process of burn wounds is complex and takes a long time. After the wound heals, sequelae such as scar contracture and functional impairment may remain. Therefore, burns, especially large-area burns, are the most complex and serious traumatic diseases. In order to treat patients with large-area severe burns, in addition to the need for specialists to have solid basic medical knowledge and experience in burns, other departments such as general surgery, cardiothoracic surgery, urology, orthopedics, anesthesiology and internal medicine need to work together for consultation and treatment to form a team to achieve success. This is the result of collective efforts, cooperation and collaborative work. Burn and scald medicines refer to medicines used to treat skin or tissue damage caused by heat (such as flames, hot water, steam), chemicals, electric current or radiation. The main functions of these medicines are to relieve pain, prevent infection, promote wound healing and reduce scar formation. According to the severity and type of burns, burn and scald medicines can be divided into topical medicines, oral medicines and new therapies. The statistical object of this article is topical medicines for burns and scalds.
The global market for burn and scald medicine is showing a steady growth trend, mainly driven by the improvement of medical standards, the increase in the incidence of burn accidents and the increase in people's health awareness. With the development of industrialization, the acceleration of urbanization and the increase in accidental injuries in the home, the demand for burn and scald treatment drugs is gradually increasing. New drugs are constantly emerging in the field of modern medicine, including growth factor drugs, bioengineered skin substitutes and silver-containing antibacterial drugs. These innovative therapies effectively improve the healing speed of wounds and reduce the risk of infection. At the same time, Chinese herbal medicine and natural plant extracts are gradually gaining market attention as auxiliary treatments, especially in Asia. The North American and European markets are dominated by advanced medical technology and high medical expenditures, while the Asia-Pacific region has become the fastest growing region due to its large population base, increased medical investment and increased public health awareness. The challenges facing the market include high drug research and development costs, complex approval processes, drug side effects and drug resistance. Major players focus on R&D innovation, expanding indications, and improving competitiveness through mergers and acquisitions and strategic cooperation. In the future, with the development of precision medicine and the promotion of personalized treatment plans, the market for burn and scald drugs is expected to maintain steady growth, especially drugs with significant wound healing effects and low side effects, which have greater market potential.
This report is a detailed and comprehensive analysis for global Burn and Scald Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Burn and Scald Medicine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Burn and Scald Medicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Burn and Scald Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Burn and Scald Medicine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Burn and Scald Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Burn and Scald Medicine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mebao Pharmaceutical Technology Group, B. Braun, Integra LifeSciences, Jinyao Darentang, Smith & Nephew, Yangtze River Pharmaceutical Group, STADA Thornton & Ross, Kenvue Brands LLC, Changchun Overseas Pharmaceutical Group Co., Ltd., Orkla Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Burn and Scald Medicine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ointment
Spray
Oil
Other
Market segment by Application
Hospitals and Clinics
Retail Pharmacies
E-commerce Platforms
Other
Major players covered
Mebao Pharmaceutical Technology Group
B. Braun
Integra LifeSciences
Jinyao Darentang
Smith & Nephew
Yangtze River Pharmaceutical Group
STADA Thornton & Ross
Kenvue Brands LLC
Changchun Overseas Pharmaceutical Group Co., Ltd.
Orkla Health
Guangdong Hengjian Pharmaceutical
Otsuka Pharmaceutical Co., Ltd.
Tonghua Maoxiang Pharmaceutical Co., Ltd.
Cipla
Tanabe Mitsubishi Pharmaceuticals
Chongqing Xixuan Biotechnology Co., Ltd.
Quest Products, LLC
Jianmin Group Yekai Thai Pharmaceutical (Suizhou)
Acme United Corp.
Dongwha Pharm
China Resources Pharmaceutical Group
Safetec Of America
Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.
North China Pharmaceutical Hebei Huanuo
Xiangxi Hongcheng Pharmaceutical
Hebei Aoxing Group Pharmaceuticals
Jilin Aodong Pharmaceutical Group
Beijing Tongrentang
Henan Quanyu Pharmaceuticals
Chengdu First Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Burn and Scald Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Burn and Scald Medicine, with price, sales quantity, revenue, and global market share of Burn and Scald Medicine from 2020 to 2025.
Chapter 3, the Burn and Scald Medicine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Burn and Scald Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Burn and Scald Medicine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Burn and Scald Medicine.
Chapter 14 and 15, to describe Burn and Scald Medicine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Burn and Scald Medicine Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Ointment
1.3.3 Spray
1.3.4 Oil
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Burn and Scald Medicine Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals and Clinics
1.4.3 Retail Pharmacies
1.4.4 E-commerce Platforms
1.4.5 Other
1.5 Global Burn and Scald Medicine Market Size & Forecast
1.5.1 Global Burn and Scald Medicine Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Burn and Scald Medicine Sales Quantity (2020-2031)
1.5.3 Global Burn and Scald Medicine Average Price (2020-2031)
2.1 Mebao Pharmaceutical Technology Group
2.1.1 Mebao Pharmaceutical Technology Group Details
2.1.2 Mebao Pharmaceutical Technology Group Major Business
2.1.3 Mebao Pharmaceutical Technology Group Burn and Scald Medicine Product and Services
2.1.4 Mebao Pharmaceutical Technology Group Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Mebao Pharmaceutical Technology Group Recent Developments/Updates
2.2 B. Braun
2.2.1 B. Braun Details
2.2.2 B. Braun Major Business
2.2.3 B. Braun Burn and Scald Medicine Product and Services
2.2.4 B. Braun Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 B. Braun Recent Developments/Updates
2.3 Integra LifeSciences
2.3.1 Integra LifeSciences Details
2.3.2 Integra LifeSciences Major Business
2.3.3 Integra LifeSciences Burn and Scald Medicine Product and Services
2.3.4 Integra LifeSciences Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Integra LifeSciences Recent Developments/Updates
2.4 Jinyao Darentang
2.4.1 Jinyao Darentang Details
2.4.2 Jinyao Darentang Major Business
2.4.3 Jinyao Darentang Burn and Scald Medicine Product and Services
2.4.4 Jinyao Darentang Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Jinyao Darentang Recent Developments/Updates
2.5 Smith & Nephew
2.5.1 Smith & Nephew Details
2.5.2 Smith & Nephew Major Business
2.5.3 Smith & Nephew Burn and Scald Medicine Product and Services
2.5.4 Smith & Nephew Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Smith & Nephew Recent Developments/Updates
2.6 Yangtze River Pharmaceutical Group
2.6.1 Yangtze River Pharmaceutical Group Details
2.6.2 Yangtze River Pharmaceutical Group Major Business
2.6.3 Yangtze River Pharmaceutical Group Burn and Scald Medicine Product and Services
2.6.4 Yangtze River Pharmaceutical Group Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
2.7 STADA Thornton & Ross
2.7.1 STADA Thornton & Ross Details
2.7.2 STADA Thornton & Ross Major Business
2.7.3 STADA Thornton & Ross Burn and Scald Medicine Product and Services
2.7.4 STADA Thornton & Ross Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 STADA Thornton & Ross Recent Developments/Updates
2.8 Kenvue Brands LLC
2.8.1 Kenvue Brands LLC Details
2.8.2 Kenvue Brands LLC Major Business
2.8.3 Kenvue Brands LLC Burn and Scald Medicine Product and Services
2.8.4 Kenvue Brands LLC Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Kenvue Brands LLC Recent Developments/Updates
2.9 Changchun Overseas Pharmaceutical Group Co., Ltd.
2.9.1 Changchun Overseas Pharmaceutical Group Co., Ltd. Details
2.9.2 Changchun Overseas Pharmaceutical Group Co., Ltd. Major Business
2.9.3 Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Product and Services
2.9.4 Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Changchun Overseas Pharmaceutical Group Co., Ltd. Recent Developments/Updates
2.10 Orkla Health
2.10.1 Orkla Health Details
2.10.2 Orkla Health Major Business
2.10.3 Orkla Health Burn and Scald Medicine Product and Services
2.10.4 Orkla Health Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Orkla Health Recent Developments/Updates
2.11 Guangdong Hengjian Pharmaceutical
2.11.1 Guangdong Hengjian Pharmaceutical Details
2.11.2 Guangdong Hengjian Pharmaceutical Major Business
2.11.3 Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Product and Services
2.11.4 Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Guangdong Hengjian Pharmaceutical Recent Developments/Updates
2.12 Otsuka Pharmaceutical Co., Ltd.
2.12.1 Otsuka Pharmaceutical Co., Ltd. Details
2.12.2 Otsuka Pharmaceutical Co., Ltd. Major Business
2.12.3 Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Product and Services
2.12.4 Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
2.13 Tonghua Maoxiang Pharmaceutical Co., Ltd.
2.13.1 Tonghua Maoxiang Pharmaceutical Co., Ltd. Details
2.13.2 Tonghua Maoxiang Pharmaceutical Co., Ltd. Major Business
2.13.3 Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product and Services
2.13.4 Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Tonghua Maoxiang Pharmaceutical Co., Ltd. Recent Developments/Updates
2.14 Cipla
2.14.1 Cipla Details
2.14.2 Cipla Major Business
2.14.3 Cipla Burn and Scald Medicine Product and Services
2.14.4 Cipla Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Cipla Recent Developments/Updates
2.15 Tanabe Mitsubishi Pharmaceuticals
2.15.1 Tanabe Mitsubishi Pharmaceuticals Details
2.15.2 Tanabe Mitsubishi Pharmaceuticals Major Business
2.15.3 Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Product and Services
2.15.4 Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Tanabe Mitsubishi Pharmaceuticals Recent Developments/Updates
2.16 Chongqing Xixuan Biotechnology Co., Ltd.
2.16.1 Chongqing Xixuan Biotechnology Co., Ltd. Details
2.16.2 Chongqing Xixuan Biotechnology Co., Ltd. Major Business
2.16.3 Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Product and Services
2.16.4 Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Chongqing Xixuan Biotechnology Co., Ltd. Recent Developments/Updates
2.17 Quest Products, LLC
2.17.1 Quest Products, LLC Details
2.17.2 Quest Products, LLC Major Business
2.17.3 Quest Products, LLC Burn and Scald Medicine Product and Services
2.17.4 Quest Products, LLC Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Quest Products, LLC Recent Developments/Updates
2.18 Jianmin Group Yekai Thai Pharmaceutical (Suizhou)
2.18.1 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Details
2.18.2 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Major Business
2.18.3 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Product and Services
2.18.4 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Recent Developments/Updates
2.19 Acme United Corp.
2.19.1 Acme United Corp. Details
2.19.2 Acme United Corp. Major Business
2.19.3 Acme United Corp. Burn and Scald Medicine Product and Services
2.19.4 Acme United Corp. Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Acme United Corp. Recent Developments/Updates
2.20 Dongwha Pharm
2.20.1 Dongwha Pharm Details
2.20.2 Dongwha Pharm Major Business
2.20.3 Dongwha Pharm Burn and Scald Medicine Product and Services
2.20.4 Dongwha Pharm Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Dongwha Pharm Recent Developments/Updates
2.21 China Resources Pharmaceutical Group
2.21.1 China Resources Pharmaceutical Group Details
2.21.2 China Resources Pharmaceutical Group Major Business
2.21.3 China Resources Pharmaceutical Group Burn and Scald Medicine Product and Services
2.21.4 China Resources Pharmaceutical Group Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 China Resources Pharmaceutical Group Recent Developments/Updates
2.22 Safetec Of America
2.22.1 Safetec Of America Details
2.22.2 Safetec Of America Major Business
2.22.3 Safetec Of America Burn and Scald Medicine Product and Services
2.22.4 Safetec Of America Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Safetec Of America Recent Developments/Updates
2.23 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.
2.23.1 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Details
2.23.2 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Major Business
2.23.3 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product and Services
2.23.4 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Recent Developments/Updates
2.24 North China Pharmaceutical Hebei Huanuo
2.24.1 North China Pharmaceutical Hebei Huanuo Details
2.24.2 North China Pharmaceutical Hebei Huanuo Major Business
2.24.3 North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Product and Services
2.24.4 North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 North China Pharmaceutical Hebei Huanuo Recent Developments/Updates
2.25 Xiangxi Hongcheng Pharmaceutical
2.25.1 Xiangxi Hongcheng Pharmaceutical Details
2.25.2 Xiangxi Hongcheng Pharmaceutical Major Business
2.25.3 Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Product and Services
2.25.4 Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 Xiangxi Hongcheng Pharmaceutical Recent Developments/Updates
2.26 Hebei Aoxing Group Pharmaceuticals
2.26.1 Hebei Aoxing Group Pharmaceuticals Details
2.26.2 Hebei Aoxing Group Pharmaceuticals Major Business
2.26.3 Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Product and Services
2.26.4 Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.26.5 Hebei Aoxing Group Pharmaceuticals Recent Developments/Updates
2.27 Jilin Aodong Pharmaceutical Group
2.27.1 Jilin Aodong Pharmaceutical Group Details
2.27.2 Jilin Aodong Pharmaceutical Group Major Business
2.27.3 Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Product and Services
2.27.4 Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.27.5 Jilin Aodong Pharmaceutical Group Recent Developments/Updates
2.28 Beijing Tongrentang
2.28.1 Beijing Tongrentang Details
2.28.2 Beijing Tongrentang Major Business
2.28.3 Beijing Tongrentang Burn and Scald Medicine Product and Services
2.28.4 Beijing Tongrentang Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.28.5 Beijing Tongrentang Recent Developments/Updates
2.29 Henan Quanyu Pharmaceuticals
2.29.1 Henan Quanyu Pharmaceuticals Details
2.29.2 Henan Quanyu Pharmaceuticals Major Business
2.29.3 Henan Quanyu Pharmaceuticals Burn and Scald Medicine Product and Services
2.29.4 Henan Quanyu Pharmaceuticals Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.29.5 Henan Quanyu Pharmaceuticals Recent Developments/Updates
2.30 Chengdu First Pharmaceuticals
2.30.1 Chengdu First Pharmaceuticals Details
2.30.2 Chengdu First Pharmaceuticals Major Business
2.30.3 Chengdu First Pharmaceuticals Burn and Scald Medicine Product and Services
2.30.4 Chengdu First Pharmaceuticals Burn and Scald Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.30.5 Chengdu First Pharmaceuticals Recent Developments/Updates
3.1 Global Burn and Scald Medicine Sales Quantity by Manufacturer (2020-2025)
3.2 Global Burn and Scald Medicine Revenue by Manufacturer (2020-2025)
3.3 Global Burn and Scald Medicine Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Burn and Scald Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Burn and Scald Medicine Manufacturer Market Share in 2024
3.4.3 Top 6 Burn and Scald Medicine Manufacturer Market Share in 2024
3.5 Burn and Scald Medicine Market: Overall Company Footprint Analysis
3.5.1 Burn and Scald Medicine Market: Region Footprint
3.5.2 Burn and Scald Medicine Market: Company Product Type Footprint
3.5.3 Burn and Scald Medicine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Burn and Scald Medicine Market Size by Region
4.1.1 Global Burn and Scald Medicine Sales Quantity by Region (2020-2031)
4.1.2 Global Burn and Scald Medicine Consumption Value by Region (2020-2031)
4.1.3 Global Burn and Scald Medicine Average Price by Region (2020-2031)
4.2 North America Burn and Scald Medicine Consumption Value (2020-2031)
4.3 Europe Burn and Scald Medicine Consumption Value (2020-2031)
4.4 Asia-Pacific Burn and Scald Medicine Consumption Value (2020-2031)
4.5 South America Burn and Scald Medicine Consumption Value (2020-2031)
4.6 Middle East & Africa Burn and Scald Medicine Consumption Value (2020-2031)
5.1 Global Burn and Scald Medicine Sales Quantity by Type (2020-2031)
5.2 Global Burn and Scald Medicine Consumption Value by Type (2020-2031)
5.3 Global Burn and Scald Medicine Average Price by Type (2020-2031)
6.1 Global Burn and Scald Medicine Sales Quantity by Application (2020-2031)
6.2 Global Burn and Scald Medicine Consumption Value by Application (2020-2031)
6.3 Global Burn and Scald Medicine Average Price by Application (2020-2031)
7.1 North America Burn and Scald Medicine Sales Quantity by Type (2020-2031)
7.2 North America Burn and Scald Medicine Sales Quantity by Application (2020-2031)
7.3 North America Burn and Scald Medicine Market Size by Country
7.3.1 North America Burn and Scald Medicine Sales Quantity by Country (2020-2031)
7.3.2 North America Burn and Scald Medicine Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8.1 Europe Burn and Scald Medicine Sales Quantity by Type (2020-2031)
8.2 Europe Burn and Scald Medicine Sales Quantity by Application (2020-2031)
8.3 Europe Burn and Scald Medicine Market Size by Country
8.3.1 Europe Burn and Scald Medicine Sales Quantity by Country (2020-2031)
8.3.2 Europe Burn and Scald Medicine Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9.1 Asia-Pacific Burn and Scald Medicine Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Burn and Scald Medicine Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Burn and Scald Medicine Market Size by Region
9.3.1 Asia-Pacific Burn and Scald Medicine Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Burn and Scald Medicine Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10.1 South America Burn and Scald Medicine Sales Quantity by Type (2020-2031)
10.2 South America Burn and Scald Medicine Sales Quantity by Application (2020-2031)
10.3 South America Burn and Scald Medicine Market Size by Country
10.3.1 South America Burn and Scald Medicine Sales Quantity by Country (2020-2031)
10.3.2 South America Burn and Scald Medicine Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11.1 Middle East & Africa Burn and Scald Medicine Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Burn and Scald Medicine Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Burn and Scald Medicine Market Size by Country
11.3.1 Middle East & Africa Burn and Scald Medicine Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Burn and Scald Medicine Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12.1 Burn and Scald Medicine Market Drivers
12.2 Burn and Scald Medicine Market Restraints
12.3 Burn and Scald Medicine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Burn and Scald Medicine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Burn and Scald Medicine
13.3 Burn and Scald Medicine Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Burn and Scald Medicine Typical Distributors
14.3 Burn and Scald Medicine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Burn and Scald Medicine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Burn and Scald Medicine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Mebao Pharmaceutical Technology Group Basic Information, Manufacturing Base and Competitors
Table 4. Mebao Pharmaceutical Technology Group Major Business
Table 5. Mebao Pharmaceutical Technology Group Burn and Scald Medicine Product and Services
Table 6. Mebao Pharmaceutical Technology Group Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Mebao Pharmaceutical Technology Group Recent Developments/Updates
Table 8. B. Braun Basic Information, Manufacturing Base and Competitors
Table 9. B. Braun Major Business
Table 10. B. Braun Burn and Scald Medicine Product and Services
Table 11. B. Braun Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. B. Braun Recent Developments/Updates
Table 13. Integra LifeSciences Basic Information, Manufacturing Base and Competitors
Table 14. Integra LifeSciences Major Business
Table 15. Integra LifeSciences Burn and Scald Medicine Product and Services
Table 16. Integra LifeSciences Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Integra LifeSciences Recent Developments/Updates
Table 18. Jinyao Darentang Basic Information, Manufacturing Base and Competitors
Table 19. Jinyao Darentang Major Business
Table 20. Jinyao Darentang Burn and Scald Medicine Product and Services
Table 21. Jinyao Darentang Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Jinyao Darentang Recent Developments/Updates
Table 23. Smith & Nephew Basic Information, Manufacturing Base and Competitors
Table 24. Smith & Nephew Major Business
Table 25. Smith & Nephew Burn and Scald Medicine Product and Services
Table 26. Smith & Nephew Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Smith & Nephew Recent Developments/Updates
Table 28. Yangtze River Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 29. Yangtze River Pharmaceutical Group Major Business
Table 30. Yangtze River Pharmaceutical Group Burn and Scald Medicine Product and Services
Table 31. Yangtze River Pharmaceutical Group Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Yangtze River Pharmaceutical Group Recent Developments/Updates
Table 33. STADA Thornton & Ross Basic Information, Manufacturing Base and Competitors
Table 34. STADA Thornton & Ross Major Business
Table 35. STADA Thornton & Ross Burn and Scald Medicine Product and Services
Table 36. STADA Thornton & Ross Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. STADA Thornton & Ross Recent Developments/Updates
Table 38. Kenvue Brands LLC Basic Information, Manufacturing Base and Competitors
Table 39. Kenvue Brands LLC Major Business
Table 40. Kenvue Brands LLC Burn and Scald Medicine Product and Services
Table 41. Kenvue Brands LLC Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Kenvue Brands LLC Recent Developments/Updates
Table 43. Changchun Overseas Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Changchun Overseas Pharmaceutical Group Co., Ltd. Major Business
Table 45. Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Product and Services
Table 46. Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Changchun Overseas Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 48. Orkla Health Basic Information, Manufacturing Base and Competitors
Table 49. Orkla Health Major Business
Table 50. Orkla Health Burn and Scald Medicine Product and Services
Table 51. Orkla Health Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Orkla Health Recent Developments/Updates
Table 53. Guangdong Hengjian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Guangdong Hengjian Pharmaceutical Major Business
Table 55. Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Product and Services
Table 56. Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Guangdong Hengjian Pharmaceutical Recent Developments/Updates
Table 58. Otsuka Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Otsuka Pharmaceutical Co., Ltd. Major Business
Table 60. Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Product and Services
Table 61. Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 63. Tonghua Maoxiang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Tonghua Maoxiang Pharmaceutical Co., Ltd. Major Business
Table 65. Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product and Services
Table 66. Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Tonghua Maoxiang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 68. Cipla Basic Information, Manufacturing Base and Competitors
Table 69. Cipla Major Business
Table 70. Cipla Burn and Scald Medicine Product and Services
Table 71. Cipla Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Cipla Recent Developments/Updates
Table 73. Tanabe Mitsubishi Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Tanabe Mitsubishi Pharmaceuticals Major Business
Table 75. Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Product and Services
Table 76. Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Tanabe Mitsubishi Pharmaceuticals Recent Developments/Updates
Table 78. Chongqing Xixuan Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 79. Chongqing Xixuan Biotechnology Co., Ltd. Major Business
Table 80. Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Product and Services
Table 81. Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Chongqing Xixuan Biotechnology Co., Ltd. Recent Developments/Updates
Table 83. Quest Products, LLC Basic Information, Manufacturing Base and Competitors
Table 84. Quest Products, LLC Major Business
Table 85. Quest Products, LLC Burn and Scald Medicine Product and Services
Table 86. Quest Products, LLC Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Quest Products, LLC Recent Developments/Updates
Table 88. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Basic Information, Manufacturing Base and Competitors
Table 89. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Major Business
Table 90. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Product and Services
Table 91. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Recent Developments/Updates
Table 93. Acme United Corp. Basic Information, Manufacturing Base and Competitors
Table 94. Acme United Corp. Major Business
Table 95. Acme United Corp. Burn and Scald Medicine Product and Services
Table 96. Acme United Corp. Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. Acme United Corp. Recent Developments/Updates
Table 98. Dongwha Pharm Basic Information, Manufacturing Base and Competitors
Table 99. Dongwha Pharm Major Business
Table 100. Dongwha Pharm Burn and Scald Medicine Product and Services
Table 101. Dongwha Pharm Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. Dongwha Pharm Recent Developments/Updates
Table 103. China Resources Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 104. China Resources Pharmaceutical Group Major Business
Table 105. China Resources Pharmaceutical Group Burn and Scald Medicine Product and Services
Table 106. China Resources Pharmaceutical Group Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. China Resources Pharmaceutical Group Recent Developments/Updates
Table 108. Safetec Of America Basic Information, Manufacturing Base and Competitors
Table 109. Safetec Of America Major Business
Table 110. Safetec Of America Burn and Scald Medicine Product and Services
Table 111. Safetec Of America Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 112. Safetec Of America Recent Developments/Updates
Table 113. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 114. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Major Business
Table 115. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product and Services
Table 116. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 117. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 118. North China Pharmaceutical Hebei Huanuo Basic Information, Manufacturing Base and Competitors
Table 119. North China Pharmaceutical Hebei Huanuo Major Business
Table 120. North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Product and Services
Table 121. North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 122. North China Pharmaceutical Hebei Huanuo Recent Developments/Updates
Table 123. Xiangxi Hongcheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 124. Xiangxi Hongcheng Pharmaceutical Major Business
Table 125. Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Product and Services
Table 126. Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 127. Xiangxi Hongcheng Pharmaceutical Recent Developments/Updates
Table 128. Hebei Aoxing Group Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 129. Hebei Aoxing Group Pharmaceuticals Major Business
Table 130. Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Product and Services
Table 131. Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 132. Hebei Aoxing Group Pharmaceuticals Recent Developments/Updates
Table 133. Jilin Aodong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 134. Jilin Aodong Pharmaceutical Group Major Business
Table 135. Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Product and Services
Table 136. Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 137. Jilin Aodong Pharmaceutical Group Recent Developments/Updates
Table 138. Beijing Tongrentang Basic Information, Manufacturing Base and Competitors
Table 139. Beijing Tongrentang Major Business
Table 140. Beijing Tongrentang Burn and Scald Medicine Product and Services
Table 141. Beijing Tongrentang Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 142. Beijing Tongrentang Recent Developments/Updates
Table 143. Henan Quanyu Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 144. Henan Quanyu Pharmaceuticals Major Business
Table 145. Henan Quanyu Pharmaceuticals Burn and Scald Medicine Product and Services
Table 146. Henan Quanyu Pharmaceuticals Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 147. Henan Quanyu Pharmaceuticals Recent Developments/Updates
Table 148. Chengdu First Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 149. Chengdu First Pharmaceuticals Major Business
Table 150. Chengdu First Pharmaceuticals Burn and Scald Medicine Product and Services
Table 151. Chengdu First Pharmaceuticals Burn and Scald Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 152. Chengdu First Pharmaceuticals Recent Developments/Updates
Table 153. Global Burn and Scald Medicine Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 154. Global Burn and Scald Medicine Revenue by Manufacturer (2020-2025) & (USD Million)
Table 155. Global Burn and Scald Medicine Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 156. Market Position of Manufacturers in Burn and Scald Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 157. Head Office and Burn and Scald Medicine Production Site of Key Manufacturer
Table 158. Burn and Scald Medicine Market: Company Product Type Footprint
Table 159. Burn and Scald Medicine Market: Company Product Application Footprint
Table 160. Burn and Scald Medicine New Market Entrants and Barriers to Market Entry
Table 161. Burn and Scald Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 162. Global Burn and Scald Medicine Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 163. Global Burn and Scald Medicine Sales Quantity by Region (2020-2025) & (K Units)
Table 164. Global Burn and Scald Medicine Sales Quantity by Region (2026-2031) & (K Units)
Table 165. Global Burn and Scald Medicine Consumption Value by Region (2020-2025) & (USD Million)
Table 166. Global Burn and Scald Medicine Consumption Value by Region (2026-2031) & (USD Million)
Table 167. Global Burn and Scald Medicine Average Price by Region (2020-2025) & (US$/Unit)
Table 168. Global Burn and Scald Medicine Average Price by Region (2026-2031) & (US$/Unit)
Table 169. Global Burn and Scald Medicine Sales Quantity by Type (2020-2025) & (K Units)
Table 170. Global Burn and Scald Medicine Sales Quantity by Type (2026-2031) & (K Units)
Table 171. Global Burn and Scald Medicine Consumption Value by Type (2020-2025) & (USD Million)
Table 172. Global Burn and Scald Medicine Consumption Value by Type (2026-2031) & (USD Million)
Table 173. Global Burn and Scald Medicine Average Price by Type (2020-2025) & (US$/Unit)
Table 174. Global Burn and Scald Medicine Average Price by Type (2026-2031) & (US$/Unit)
Table 175. Global Burn and Scald Medicine Sales Quantity by Application (2020-2025) & (K Units)
Table 176. Global Burn and Scald Medicine Sales Quantity by Application (2026-2031) & (K Units)
Table 177. Global Burn and Scald Medicine Consumption Value by Application (2020-2025) & (USD Million)
Table 178. Global Burn and Scald Medicine Consumption Value by Application (2026-2031) & (USD Million)
Table 179. Global Burn and Scald Medicine Average Price by Application (2020-2025) & (US$/Unit)
Table 180. Global Burn and Scald Medicine Average Price by Application (2026-2031) & (US$/Unit)
Table 181. North America Burn and Scald Medicine Sales Quantity by Type (2020-2025) & (K Units)
Table 182. North America Burn and Scald Medicine Sales Quantity by Type (2026-2031) & (K Units)
Table 183. North America Burn and Scald Medicine Sales Quantity by Application (2020-2025) & (K Units)
Table 184. North America Burn and Scald Medicine Sales Quantity by Application (2026-2031) & (K Units)
Table 185. North America Burn and Scald Medicine Sales Quantity by Country (2020-2025) & (K Units)
Table 186. North America Burn and Scald Medicine Sales Quantity by Country (2026-2031) & (K Units)
Table 187. North America Burn and Scald Medicine Consumption Value by Country (2020-2025) & (USD Million)
Table 188. North America Burn and Scald Medicine Consumption Value by Country (2026-2031) & (USD Million)
Table 189. Europe Burn and Scald Medicine Sales Quantity by Type (2020-2025) & (K Units)
Table 190. Europe Burn and Scald Medicine Sales Quantity by Type (2026-2031) & (K Units)
Table 191. Europe Burn and Scald Medicine Sales Quantity by Application (2020-2025) & (K Units)
Table 192. Europe Burn and Scald Medicine Sales Quantity by Application (2026-2031) & (K Units)
Table 193. Europe Burn and Scald Medicine Sales Quantity by Country (2020-2025) & (K Units)
Table 194. Europe Burn and Scald Medicine Sales Quantity by Country (2026-2031) & (K Units)
Table 195. Europe Burn and Scald Medicine Consumption Value by Country (2020-2025) & (USD Million)
Table 196. Europe Burn and Scald Medicine Consumption Value by Country (2026-2031) & (USD Million)
Table 197. Asia-Pacific Burn and Scald Medicine Sales Quantity by Type (2020-2025) & (K Units)
Table 198. Asia-Pacific Burn and Scald Medicine Sales Quantity by Type (2026-2031) & (K Units)
Table 199. Asia-Pacific Burn and Scald Medicine Sales Quantity by Application (2020-2025) & (K Units)
Table 200. Asia-Pacific Burn and Scald Medicine Sales Quantity by Application (2026-2031) & (K Units)
Table 201. Asia-Pacific Burn and Scald Medicine Sales Quantity by Region (2020-2025) & (K Units)
Table 202. Asia-Pacific Burn and Scald Medicine Sales Quantity by Region (2026-2031) & (K Units)
Table 203. Asia-Pacific Burn and Scald Medicine Consumption Value by Region (2020-2025) & (USD Million)
Table 204. Asia-Pacific Burn and Scald Medicine Consumption Value by Region (2026-2031) & (USD Million)
Table 205. South America Burn and Scald Medicine Sales Quantity by Type (2020-2025) & (K Units)
Table 206. South America Burn and Scald Medicine Sales Quantity by Type (2026-2031) & (K Units)
Table 207. South America Burn and Scald Medicine Sales Quantity by Application (2020-2025) & (K Units)
Table 208. South America Burn and Scald Medicine Sales Quantity by Application (2026-2031) & (K Units)
Table 209. South America Burn and Scald Medicine Sales Quantity by Country (2020-2025) & (K Units)
Table 210. South America Burn and Scald Medicine Sales Quantity by Country (2026-2031) & (K Units)
Table 211. South America Burn and Scald Medicine Consumption Value by Country (2020-2025) & (USD Million)
Table 212. South America Burn and Scald Medicine Consumption Value by Country (2026-2031) & (USD Million)
Table 213. Middle East & Africa Burn and Scald Medicine Sales Quantity by Type (2020-2025) & (K Units)
Table 214. Middle East & Africa Burn and Scald Medicine Sales Quantity by Type (2026-2031) & (K Units)
Table 215. Middle East & Africa Burn and Scald Medicine Sales Quantity by Application (2020-2025) & (K Units)
Table 216. Middle East & Africa Burn and Scald Medicine Sales Quantity by Application (2026-2031) & (K Units)
Table 217. Middle East & Africa Burn and Scald Medicine Sales Quantity by Country (2020-2025) & (K Units)
Table 218. Middle East & Africa Burn and Scald Medicine Sales Quantity by Country (2026-2031) & (K Units)
Table 219. Middle East & Africa Burn and Scald Medicine Consumption Value by Country (2020-2025) & (USD Million)
Table 220. Middle East & Africa Burn and Scald Medicine Consumption Value by Country (2026-2031) & (USD Million)
Table 221. Burn and Scald Medicine Raw Material
Table 222. Key Manufacturers of Burn and Scald Medicine Raw Materials
Table 223. Burn and Scald Medicine Typical Distributors
Table 224. Burn and Scald Medicine Typical Customers
List of Figures
Figure 1. Burn and Scald Medicine Picture
Figure 2. Global Burn and Scald Medicine Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Burn and Scald Medicine Revenue Market Share by Type in 2024
Figure 4. Ointment Examples
Figure 5. Spray Examples
Figure 6. Oil Examples
Figure 7. Other Examples
Figure 8. Global Burn and Scald Medicine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Burn and Scald Medicine Revenue Market Share by Application in 2024
Figure 10. Hospitals and Clinics Examples
Figure 11. Retail Pharmacies Examples
Figure 12. E-commerce Platforms Examples
Figure 13. Other Examples
Figure 14. Global Burn and Scald Medicine Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Burn and Scald Medicine Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Burn and Scald Medicine Sales Quantity (2020-2031) & (K Units)
Figure 17. Global Burn and Scald Medicine Price (2020-2031) & (US$/Unit)
Figure 18. Global Burn and Scald Medicine Sales Quantity Market Share by Manufacturer in 2024
Figure 19. Global Burn and Scald Medicine Revenue Market Share by Manufacturer in 2024
Figure 20. Producer Shipments of Burn and Scald Medicine by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 21. Top 3 Burn and Scald Medicine Manufacturer (Revenue) Market Share in 2024
Figure 22. Top 6 Burn and Scald Medicine Manufacturer (Revenue) Market Share in 2024
Figure 23. Global Burn and Scald Medicine Sales Quantity Market Share by Region (2020-2031)
Figure 24. Global Burn and Scald Medicine Consumption Value Market Share by Region (2020-2031)
Figure 25. North America Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 26. Europe Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 27. Asia-Pacific Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 28. South America Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 29. Middle East & Africa Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 30. Global Burn and Scald Medicine Sales Quantity Market Share by Type (2020-2031)
Figure 31. Global Burn and Scald Medicine Consumption Value Market Share by Type (2020-2031)
Figure 32. Global Burn and Scald Medicine Average Price by Type (2020-2031) & (US$/Unit)
Figure 33. Global Burn and Scald Medicine Sales Quantity Market Share by Application (2020-2031)
Figure 34. Global Burn and Scald Medicine Revenue Market Share by Application (2020-2031)
Figure 35. Global Burn and Scald Medicine Average Price by Application (2020-2031) & (US$/Unit)
Figure 36. North America Burn and Scald Medicine Sales Quantity Market Share by Type (2020-2031)
Figure 37. North America Burn and Scald Medicine Sales Quantity Market Share by Application (2020-2031)
Figure 38. North America Burn and Scald Medicine Sales Quantity Market Share by Country (2020-2031)
Figure 39. North America Burn and Scald Medicine Consumption Value Market Share by Country (2020-2031)
Figure 40. United States Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 41. Canada Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 42. Mexico Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 43. Europe Burn and Scald Medicine Sales Quantity Market Share by Type (2020-2031)
Figure 44. Europe Burn and Scald Medicine Sales Quantity Market Share by Application (2020-2031)
Figure 45. Europe Burn and Scald Medicine Sales Quantity Market Share by Country (2020-2031)
Figure 46. Europe Burn and Scald Medicine Consumption Value Market Share by Country (2020-2031)
Figure 47. Germany Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 48. France Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 49. United Kingdom Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 50. Russia Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 51. Italy Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 52. Asia-Pacific Burn and Scald Medicine Sales Quantity Market Share by Type (2020-2031)
Figure 53. Asia-Pacific Burn and Scald Medicine Sales Quantity Market Share by Application (2020-2031)
Figure 54. Asia-Pacific Burn and Scald Medicine Sales Quantity Market Share by Region (2020-2031)
Figure 55. Asia-Pacific Burn and Scald Medicine Consumption Value Market Share by Region (2020-2031)
Figure 56. China Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 57. Japan Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 58. South Korea Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 59. India Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 60. Southeast Asia Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 61. Australia Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 62. South America Burn and Scald Medicine Sales Quantity Market Share by Type (2020-2031)
Figure 63. South America Burn and Scald Medicine Sales Quantity Market Share by Application (2020-2031)
Figure 64. South America Burn and Scald Medicine Sales Quantity Market Share by Country (2020-2031)
Figure 65. South America Burn and Scald Medicine Consumption Value Market Share by Country (2020-2031)
Figure 66. Brazil Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 67. Argentina Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 68. Middle East & Africa Burn and Scald Medicine Sales Quantity Market Share by Type (2020-2031)
Figure 69. Middle East & Africa Burn and Scald Medicine Sales Quantity Market Share by Application (2020-2031)
Figure 70. Middle East & Africa Burn and Scald Medicine Sales Quantity Market Share by Country (2020-2031)
Figure 71. Middle East & Africa Burn and Scald Medicine Consumption Value Market Share by Country (2020-2031)
Figure 72. Turkey Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 73. Egypt Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 74. Saudi Arabia Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 75. South Africa Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
Figure 76. Burn and Scald Medicine Market Drivers
Figure 77. Burn and Scald Medicine Market Restraints
Figure 78. Burn and Scald Medicine Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Burn and Scald Medicine in 2024
Figure 81. Manufacturing Process Analysis of Burn and Scald Medicine
Figure 82. Burn and Scald Medicine Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Mebao Pharmaceutical Technology Group B. Braun Integra LifeSciences Jinyao Darentang Smith & Nephew Yangtze River Pharmaceutical Group STADA Thornton & Ross Kenvue Brands LLC Changchun Overseas Pharmaceutical Group Co., Ltd. Orkla Health Guangdong Hengjian Pharmaceutical Otsuka Pharmaceutical Co., Ltd. Tonghua Maoxiang Pharmaceutical Co., Ltd. Cipla Tanabe Mitsubishi Pharmaceuticals Chongqing Xixuan Biotechnology Co., Ltd. Quest Products, LLC Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Acme United Corp. Dongwha Pharm China Resources Pharmaceutical Group Safetec Of America Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. North China Pharmaceutical Hebei Huanuo Xiangxi Hongcheng Pharmaceutical Hebei Aoxing Group Pharmaceuticals Jilin Aodong Pharmaceutical Group Beijing Tongrentang Henan Quanyu Pharmaceuticals Chengdu First Pharmaceuticals
Related Reports
28 Jan 2025
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
